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CLIMATE CHANGE AND HEALTH:
A TOOL TO ESTIMATE HEALTH AND ADAPTATION COSTS
ABSTRACT
The WHO Regional Office for Europe prepared this economic analysis tool to support health adaptation planning in 
European Member States. It is based on a review of the science. It is expected to be applied in Member States mainly 
by line ministries responsible for climate change adaptation. It provides step-by-step guidance on estimating (a) the 
costs associated with damage to health due to climate change, (b) the costs for adaptation in various sectors to protect 
health from climate change and (c) the efficiency of adaptation measures, i.e. the cost of adaptation versus the expected 
returns, or averted health costs. The tool consists of a document describing the methods step-by-step and a manual with 
an Excel spreadsheet, which is a visual aid for calculating costs. To obtain the Excel spreadsheet, please send an e-mail to 
climatechange@ecehbonn.euro.who.int.
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 Foreword
Climate change is affecting human health. Its effect—largely negative—has been observed in 
several countries of the WHO European Region throughout the last few decades, continues 
today and is projected to worsen under probable climate scenarios. In order to cope with this 
emerging threat, authorities must evaluate current impacts and the vulnerability of their health 
systems and then prepare and implement adequate adaptation measures. 
The best available evidence should be used in planning adaptation to protect health from climate 
change. In the context of limited public resources and competing priorities, the evidence should 
include estimates of the costs and benefits of taking action and the economic consequences of 
not doing so. The economic toolkit in this document will assist decision-makers in making such 
evaluations by providing explicit economic costs of the health impacts of climate change and 
the planned costs of adaptation. 
The WHO Regional Office for Europe prepared this economic analysis tool to support health 
adaptation planning in Member States. It is based on a review of the science, with substantive 
input from several experts in the field. It is expected to be applied in Member States mainly by 
line ministries responsible for climate change adaptation. It will enable analysts at both regional 
and country level to generate better, more standardized economic data, help build vital capacity 
for health economic assessments and provide a link to decision-makers. The health impacts of 
climate change not only cause suffering but also entail avoidable economic costs. Adequate 
adaptation can reduce those costs and even bring additional economic benefits through hitherto 
unrealized opportunities. Economic data can help decision-makers to stress the benefits of 
adaptation, strengthening the case for early action against climate change.
This tool will support the efforts of WHO Member States to meet the commitment to act made 
at the Fifth Ministerial Conference on Environment and Health, act on World Health Assembly 
resolution WHA62.19 and implement the United Nations Framework Convention on Climate 
Change (UNFCCC). 
Srđan Matić
Coordinator
Division of Communicable Diseases, 
Health Security and Environment
WHO Regional Office for Europe
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 Executive summary
Climate change entails a wide variety of public health risks. Authorities and other stakeholders 
thus need to understand current and projected impacts of climate change and their implications 
for health in order to prepare and implement a variety of responses to ensure an optimal level of 
adaptation. Examples of such responses include early warning systems, emergency management 
plans and provisions and health systems strengthening; other preventive measures include safer 
housing, flood protection, vector control and improved surveillance.
To ensure that timely, effective adaptation measures are taken, planners must provide coherence 
among sectors and levels of governance. This strategic approach requires an objective 
understanding of the full health-related economic implications of climate change and of the 
range of alternative or complementary adaptation activities. In general, adaptation planners 
need to know (1) the costs of inaction and the economic consequences of the health impacts 
of climate change; (2) the costs of action, including adaptation measures in the health sector 
and also those taken in other sectors to protect health; and (3) the residual costs, as adaptation 
measures usually cannot avert all climate-related health impacts. This economic valuation tool 
can help to analyse these costs and benefits. It comprises three main economic components: 
• the health damage costs associated with a “business-as-usual” (i.e. no adaptation) scenario 
under climate change;
• the costs of undertaking the necessary measures to minimize or prevent the health damage 
of climate change; and
• summary indicators of the economic performance of adaptation measures, in terms of either 
cost–effectiveness or economic benefits versus costs. 
These economic components can be calculated with the valuation tool described in this 
document. As a visual aid for application of the tool, a simple Excel file is available upon 
request to the WHO Regional Office for Europe (climatechange@ecehbonn.euro.who.int), 
which consists of three spreadsheets for data input and two spreadsheets for output. The method 
(with the supporting spreadsheets) can be applied either at the national level of aggregation or 
at the subnational level.
Some of the input required for its application is beyond the scope of this tool. Thus, the analytical 
team should ascertain the components of health damage due to climate change before applying 
the economic tool. These data can be obtained either from existing national (or subnational) 
assessments of vulnerability, impact and adaptation or from studies on specific health outcomes. 
If these are not available, a health impact assessment must be carried out before estimating the 
costs. WHO provides guidance on quantifying the health impact of climate change at national 
and local levels and other resources to assist Member States in their adaptation efforts.
VII
11 Marginal budgeting for bottlenecks tool (United Nations Children’s Fund, World Bank, Asian Development Bank, 2012); the WHO CHOICE 
model (WHO, 2003a); the WHO integrated health care technology package (WHO, South African Medical Research Council, 2013); MDG 
needs assessment tools (United Nation Development Programme, 2010); and the OneHealth impact model (Inter-agency Working Group, 
2011)
1. Introduction
Over the past few years, scientists have shown unequivocally that the climate system is warming. 
Climate change has already affected human health directly by changing weather patterns 
(temperature, precipitation, sea-level rise and more frequent extreme events) and indirectly by 
changing water, air and food quality and the planet’s life support systems. Tackling the root 
causes of climate change, investing in healthy environments, strengthening health systems and 
advocating for healthy development could reduce the burden of disease and promote population 
health (Menne et al., 2007). 
The European Commitment to Act, endorsed at the Fifth European Ministerial Conference on 
Environment and Health in Parma, Italy, in 2010, commits European Member States to protect 
health and well-being, natural resources and ecosystems and to promote health equity, health 
security and healthy environments in a changing climate. 
World Health Assembly resolution WHA61.19 (WHO, 2008) urges Member States to prepare 
adaptation strategies and responses. In many cases, health is an integrated component of these 
health adaptation action plans, while in others additional plans are being prepared. 
1.1 Aims
The WHO Regional Office for Europe prepared this economic analysis tool as a support for 
adaptation planning for health in Member States. Specifically, it will assist in:
• estimating the costs of health damage due to climate change at national and subnational 
levels;
• estimating the costs of health-relevant adaptation to climate change at national and 
subnational levels; and 
• comparing the cost of health damage averted with the cost of adaptation measures, in order 
to reach conclusions on value for money. 
While several health costing tools exist1 this tool is specific for climate change and allows the 
user to conduct relatively simple analyses. Depending on requirements and capacity, the user 
can choose how detailed the data should be, the level of disaggregation of inputs and outputs 
and whether additional research should be undertaken.
This tool is intended for use by health or environment managers and stakeholders in estimating 
health damage and adaptation costs. It is expected that it will be used mainly in ministries 
responsible for climate change adaptation, including ministries of health. Government 
departments can expect to be supported, if necessary, by academic institutions and other partners 
with strong technical and analytical skills in applying the principles, including possible support 
from international partners (other governments or multilateral agencies). The document might 
also provide useful information for universities and others involved in assessing health-related 
impacts of climate change. 
Several types of technical knowledge are needed to use the tool, including economics, 
epidemiology, public health and health information. The user should be prepared to seek 
information from several ministries and from public health and health care institutions.
21.2 Why this tool was prepared
McMichael (2013) wrote, “The complex nature of climate change and its environmental 
and social manifestations result in diverse risks to human health”. The increases in some 
adverse health impacts are already large enough that they can be attributed to recent climate 
change, while more significant effects are projected for the coming decades and centuries 
(Confalonieri et al., 2007). Fig. 1 illustrates some of the observed and expected health impacts 
of climate change.
Fig. 1. Economic analysis of the health impacts of and adaptation to climate change
 
Source: Adapted from McMichael (2013).
It is clear that the atmospheric concentration of greenhouse gases will rise to levels that will 
have significant, wide-ranging, net negative health impacts during the twenty-first century. 
The challenge for policy-makers is to understand the current and projected impacts of climate 
change and their implications for health and to prepare and implement a variety of responses to 
ensure optimal adaptation. This range of responses includes, for example emergency response, 
disaster recovery and support to environmental refugees; strengthening health systems to treat 
diseases and health conditions as they occur; and preventive measures, such as safer housing, 
flood protection, vector control, improved surveillance, early warning information systems and 
community-based disaster risk reduction. 
A strategic approach is needed to ensure that timely, effective adaptation measures are taken 
that are coherent across different sectors and levels of government. This strategic approach 
32 In the case of health, residual damage equals (1) the total health costs attributed to climate change minus (2) the health costs that could be 
averted through adaptation measures.
requires objective understanding of the full economic and financial impacts of climate change 
and the alternative and complementary actions available to respond to these health threats.
Specifically, adaptation planners must know the costs of inaction, the costs of action and the costs 
of residual damage.2 This means taking account of the costs and benefits incurred by the various 
stakeholders, their interests and the relationships and flow of resources among them (Box 1). 
It also means clarifying the types of economic impact: distinguishing between measures that 
require additional cash outlay, additional budget allocations or displacement of budget from 
other activities and those that involve use of resources that do not require additional cash outlay 
but have a clear and identifiable opportunity cost (i.e. could be used in alternative activities). 
The level of cost of adaptation to climate change is largely a matter of perspective, as explained 
in Box 1.
Box 1. Interests of different stakeholders in knowing health and adaptation costs 
• International climate change financers: comparison of costs and returns of increased 
health spending on different programmes or in different countries
• Ministries of finance: overview of the budget impact or additional budget requirements 
of all government sectors for informed resource allocation per sector or line ministry 
• Line ministries: budgetary and resource deployment of a ministry and working with 
other ministries or the private sector to mobilize support for programmes
• Households: expected cash outlays, other resource investments and use of cheaper or 
subsidized services or products
• Private sector providers: business opportunities for the supply of goods and services
Therefore, in the context of health adaptation planning, the main questions addressed in an 
economic evaluation are the following. 
• What evidence is available to support decisions on appropriate allocations to reduce the 
health impacts of climate change? 
• How much will the actions cost and what benefits can they bring about? 
In 2010–2011, the WHO Regional Office for Europe carried out a literature review (co-funded 
by the European Commission) covering the 53 countries of the WHO European Region to 
identify and assess studies of the economic cost of adaptation to reduce the health implications 
of climate change. The review showed the following. 
• There are very few European-wide studies that provide a comprehensive overview of the 
health and adaptation costs of climate change. 
• Economic outcomes are analysed and reported differently in different studies, making 
comparison or compilation difficult. 
• Only a narrow range of health impacts has so far been included in damage and adaptation 
cost estimates. 
• There are significant gaps in health impact research, and health outcomes are not analysed 
by unit attributed to climate change. 
• Information is needed on baseline mitigation and adaptation scenarios in view of the long-
term nature of climate change. 
4The tool described in this manual will enable analysts at both regional and country levels to 
generate improved, more standardized economic data, build capacity for health economic 
assessments and provide a link to decision-makers.
 
1.3 Information that can be generated 
With numerical input and simple calculations, a range of damage, adaptation and efficiency 
ratios can be generated with this tool (Table 1). 
Table 1. Major quantitative outputs of the tool
Health damage costs
• Total national annual cost of climate change-induced health effects
• Total national annual cost of climate change-induced health effects as a proportion of 
gross domestic product (GDP) (damage cost ÷ total GDP)
• Annual cost per capita of climate change-induced health impacts, for example:
 ◦ Total costs associated with climate-attributed health effects as a proportion of total 
damage costs associated with all health risks to society; requires data from studies of 
overall damage costs
 ◦ Evolution over time to estimate the changing importance of health effects due to climate 
change
• Annual projected additional cases of climate change-induced injuries, diseases and 
resulting disability-adjusted life-years (DALYs)
Health adaptation costs
• Annual costs to (partially) reduce climate change-induced health effects 
 ◦ by disease grouping
 ◦ by financing agency and line ministry
• Annual health adaptation costs as a percentage of annual budget
• Evolution of the above over time (to estimate changing adaptation costs)
Efficiency ratios
• Health damage costs averted by spending a unit of money on adaptation measures
• Cost spent per health unit gained 
Both public budgets and private funds to address new health threats, such as climate change, are 
constrained. In order to maximize the return on investments, spending on adaptation measures 
should be rational and should respond in a cost-effective manner to the risks and opportunities 
associated with climate change. Therefore, decision-makers—both government and private—
need a strengthened evidence base and tools to help them distribute the right amount of funds 
and resources to safeguard health from climate change. This tool can support decision-makers 
in the health sector and other health-relevant areas to generate information for the following. 
• Impact analysis focuses on health, social or environmental impacts of climate change, 
thus providing information for health impact analysis (or assessment), risk or vulnerability 
assessment and Intervention impact assessment. 
5• Economic analysis guides general policy or specific projects and programmes, including 
“damage” cost assessment (i.e. cost of no action); cost of measures to reduce the health 
impacts of climate change; and health economic evaluation to compare the costs and 
benefits of alternative policy measures to reduce the health impacts of climate change. 
Health economic evaluation includes cost–benefit analysis, cost–effectiveness analysis and 
cost–utility analysis (see Glossary).
• Planning tools define programme and project approaches or components to prevent or 
minimize the health impacts of climate change, including budgeting, results monitoring 
(e.g. the logical framework “logframe” approach); analysis of strengths, weaknesses, 
opportunities and threats (SWOT); and multicriteria analysis.
• Policy studies allow consideration of strategic issues, such as political, contextual and 
human factors, that affect decisions or their implementation, including project evaluation, 
strategic assessment and stakeholder analysis.
The outputs of some tools commonly feed into others. For example, health impact studies form 
the basis for economic analyses, and, in turn, economic analyses provide input for planning or 
policy studies (see Fig. 2). Before decisions are taken, attempts should be made to compile all 
the relevant information for making informed choices. For example, if only health impacts are 
considered in a decision on resource allocation, the costs of interventions (i.e. efficiency) are not 
taken into account, thus reducing the proportion of people who could benefit from alternative, 
more cost-effective interventions. If a cost–benefit analysis includes only monetized variables, 
it will omit effects other than those on the market. Tools such as multicriteria analysis allow a 
broader perspective, enabling the user to compare and contrast different outcomes, with explicit 
rules for balancing a range of information. Many of these analyses are enhanced by including 
scenario testing and sensitivity analysis, which aid decision-making when there is uncertainty. 
Fig. 2. Links among decision-making tools and decision outputs
Note. M&E: monitoring and evaluation. 
61.4 Economic components 
Climate change has a wide range of implications for human health, including increased mortality 
and morbidity from extreme temperatures and other extreme weather events, infectious diseases 
(waterborne, foodborne and vector-borne) and diseases resulting from air pollution (WHO, 
2009). Aside from the pain and suffering caused, those illnesses result in premature mortality, 
additional use of health care and lost productivity, thus burdening individuals and society with 
additional, partially avoidable loss of welfare, which can be translated into an economic cost. 
Societies and authorities can put in place policies, plans and projects to cope with or avoid 
the impacts of climate change, including on health. These activities are known jointly as 
“adaptation”. They can reduce not only health effects but also the economic costs associated 
with premature mortality, health care use and lost productivity (Bosello, Roson, Tol, 2006; 
Ebi, 2008). Furthermore, effective adaptation may bring additional economic benefits through 
hitherto unrealized opportunities. The economic savings and potential benefits of health-
relevant adaptation must be measured against the costs of implementing adaptation measures. 
This economic valuation tool can help in analysing these costs and benefits. It comprises three 
main economic components: 
• the health damage costs associated with a “business-as-usual” (i.e. no adaptation) scenario; 
• the costs of undertaking the necessary measures to minimize or prevent health damage due 
to climate change; and
• summary indicators of the economic performance of adaptation measures, in terms of either 
cost–effectiveness or economic benefits versus costs. 
Health costs (alternatively called “health damage costs”or “the health costs of inaction”) are 
defined in this tool as “the costs associated with climate change in the absence of planned 
adaptation or mitigation responses”. The objective of health costing analysis in the context of 
climate change is to show decision-makers the costs of inaction and to provide material for 
advocacy to raise attention about climate change, highlighting the value of health effects and 
the need to avert or reduce them. 
Some previous health cost studies estimated the numbers of excess or attributable deaths due 
to climate change and multiplied them by the average value of life (a global value or a value 
based on GDP per capita of the country or region in which the deaths are expected to occur), 
to arrive at a total welfare loss (Tol, 1995; Fankhauser and Tol, 1997; Tol, 2002). Some studies 
also include the costs of treating additional cases of illness (Bosello, Roson, Tol, 2006; Watkiss 
et al., 2009). To date, health cost studies of mortality have focused mainly on heat or cold stress 
and in some cases natural disasters. With more comprehensive coverage of health impacts, 
the picture will be more complete and, importantly, more accurate. Importantly, the economic 
analysis will be more comprehensive, and more socially optimal decisions will result. 
The true health costs of climate change extend beyond monetary estimates and cannot be 
described solely in that way. In the context of policy evaluation, money is only a proxy for 
welfare. Moreover, the impacts on welfare are felt differently by different population groups. 
If a health impact and its associated cost fall on two individuals with widely different incomes, 
the effect will be different. Hence, analysts should explore interpretations beyond aggregate 
numbers.
Health adaptation costs are defined here as “the costs of taking measures to reduce or to cope 
with additional impacts arising as a result of climate change”. The objective of these studies is 
7to identify the expenditure required for specific actions and thus allow realistic budgeting by 
fund-holding decision-makers. In adaptation cost studies, the health impacts of climate change 
are commonly used as a basis for estimating the cost of either preventing the impact or treating 
the effect once it has occurred. Adaptation cost studies have so far generally focused on vector-
borne disease (malaria), waterborne disease (diarrhoea) and malnutrition (Ebi, 2008; Margulis 
and Narain, 2009). 
As to summary indicators, the tool also facilitates health economic valuation, in which the 
costs and benefits of health adaptation measures are compared, with an estimate of a return on 
spending in the form of a cost–effectiveness ratio (such as cost per death averted) or a cost–
benefit ratio (monetary return per currency unit spent). These summary indicators are provided 
to help understanding of the overall results of the calculations, but, ultimately, disaggregated 
information on health damage costs and adaptation costs and benefits should be taken into 
account in making a decision. 
1.5 Input required 
The valuation tool described in this manual addresses the economic aspects of the health impacts 
of climate change, and of the adaptation measures and policies needed to minimize those 
impacts. Some input necessary for its application, however, requires additional analysis, which 
is beyond the scope of this tool. Fig. 3 illustrates the methodological steps in a full analysis. 
The steps in the red squares are to be undertaken either before the economic assessment (health 
damage) or additionally (effectiveness of adaptation). 
 
Fig. 3. Economic analysis of the health impacts of adaptation to climate change
8Specifically, analysts must ascertain the health damage components of climate change before 
using the tool. These can be obtained either from existing national or subnational assessments 
of vulnerability, impact and adaptation; or studies may be available on specific health outcomes, 
from which mortality and morbidity attributable to climate change can be obtained. If these are 
not available, a health impact assessment must be carried out before costs are estimated. 
WHO provides guidance on quantifying the health impact of climate change at national and 
local levels, as well as other resources to assist Member States in adaptation (see annexes). In 
addition, there is a growing body of national and subnational studies on the effects of climate 
variables and/or climate change on a wide range of health outcomes. Relevant examples include 
the health effects of temperature (Ballester et al., 2011; Schifano et al., 2012), tick-borne diseases 
(Danielová et al., 2010) and flood-related mortality and morbidity (Jakubicka et al., 2010). The 
relevant literature in this field has been summarized elsewhere (Confalonieri et al., 2007). 
Much additional research is required to understand the effectiveness of public health adaptation 
measures in decreasing mortality and morbidity related to climate change. To date, there has 
been no comprehensive study on the matter. This tool will allow rough sensitivity analyses to 
be conducted in the absence of specific data. 
1.6 Structure
The tool consists of a manual describing the steps and inputs required and the methods, 
data and analysis for filling in data sheets. The Excel spreadsheet comprises five worksheets 
 – three for data input and two for outputs, which include integrated formulas to facilitate 
calculations. It can be requested directly from the WHO Regional Office for Europe via e-mail 
(climatechange@ecehbonn.euro.who.int). 
The tool was developed by conducting an extensive literature review, with expert advice and 
expert review. It was pilot tested in the former Yugoslav Republic of Macedonia.
2. Manual for calculating health and adaptation costs
Four steps are described for making estimates, applying the calculations proposed to assess the 
health cost of inaction, the cost of adaptation and efficiency ratios, and data input and analysis 
(Fig. 4). In the Excel file available to support application of the method, the data inputs are 
labelled “D” for damage cost and “A” for adaptation cost.
2.1 Step 1. Define the scope 
Before starting data collection and analysis, the scope of the assessment must be defined. The 
party that initiates the analysis must decide on the main question to be answered, for instance: 
• To raise attention to climate change, highlighting the health effects and the need to avert or 
reduce those effects: a health damage cost analysis should be conducted.
• To identify the expenditure required for specific health actions to allow realistic budgeting 
by fund-holding decision-makers: a health adaptation cost analysis should be conducted. 
• To compare the costs of adaptation measures with the health costs that could be averted by 
such measures: both a health cost and an adaptation cost analysis, with an assessment of the 
proportion of health impacts that could be averted by adaptation measures. 
9Fig. 4. Steps in assessing health damage and adaptation costs
Once the type(s) of analysis are decided, the analyst should specify whether the tool is to be 
applied at national and/or subnational level, the types of disease to be included, the population 
groups for which disaggregated output data are required (which depends on the disaggregated 
input data that can be provided) and the period of the analysis. 
2.2 Step 2. Methods, data, sources, and analysis
The mechanics and the types of input required to apply the method with the spreadsheet tool are 
described below for estimating health damage costs and adaptation costs. 
2.2.1 Estimating the cost of damage to health
2.2.1.1 Methodological considerations
2.2.1.1.1 Level of application
The method (and the supporting Excel spreadsheet) can be applied at either the national or 
the subnational level of aggregation but not at both simultaneously. If both are required (for 
example, at national level and also at a particularly climate-sensitive location), the Excel file 
should be copied and the sheets filled in separately for each level. This solution will require an 
additional worksheet for summarizing damage costs at both national and subnational levels. An 
assessment should be made of whether subnational disaggregation is important to show that 
some parts of a country need more urgent attention than others.
Other types of disaggregation are possible, such as by disease type, rural–urban location, age 
group, income group or sex. In each application of the Excel tool (e.g. “health cost” worksheet), 
up to 10 disaggregations are possible. The most important should be determined on the basis 
of their relevance to the policy decision or for advocacy (e.g. showing that some population 
groups are more affected than others).
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2.2.1.1.2 Cost disaggregation (economic and financial)
To avoid overly burdensome data collection requirements and cumbersome spreadsheets, only 
a simple twofold cost disaggregation is proposed, which distinguishes between full welfare 
value and short-term budget impact. This disaggregation is expected to be understandable 
and meaningful for most decision-makers. It is useful for them to have overall estimates of 
impact on welfare and of the broader consequences for society of “doing nothing”, although 
they are also interested in direct budgetary implications. Further disaggregation of unit cost is 
not recommended for the damage cost tool (e.g. breaking costs down into labour costs, capital 
costs and materials). If the data are available, however, further disaggregation can be conducted 
for different population groups to allow a finer interpretation of the welfare impacts of the 
monetary costs. This might be useful, for example, when a given monetary loss is greater for 
some groups (e.g. the poor) than for others (e.g. the rich).
2.2.1.1.3 Time horizon and discounting
The “time horizon” is the number of years for which damage costs are to be measured. Owing to 
the time preference for money, the economic assessment “discounts” future costs and benefits 
to a common baseline year. The selection of the time horizon can be based on a commonly 
used number, such as 20 years, as used in many cost–benefit analysis studies, 100 years (WHO, 
2003b) or another time based on a predefined rule. In assessing damage cost, two main factors 
are taken into account in deciding the time horizon: 
• The size of the discount rate is the first. The higher the discount rate, the less future economic 
impacts are worth in the present. At a 3% discount rate (a common value in the evaluation 
of environmental policies) impacts in 24 years are worth half what they are today; at a 5% 
discount rate, impacts in 15 years are worth half what they are today; at an 8% discount rate, 
impacts in 9 years are worth half what they are today.
• The second is the behaviour of health impacts over time. In the case of diseases that are 
causing a diminishing number of cases over time because of successful control policies, 
there would be clear arguments for reducing the time horizon. In damage cost estimation of 
climate-related diseases that are expected to increase over time with little or no mitigation, 
there would be justification for extending the time horizon.
The model allows for 15 single-year periods from 2006 to 2020 (see “start year”, below); 
however, the start year can be changed and the number of years adjusted. To allow for longer 
time horizons, seven decade periods until 2100 are included in the spreadsheet. The future 
health costs expressed in current prices are likely to be important only if a very low or zero 
discount rate is chosen. After 100 years at a 3% discount rate, however, the impacts are worth 
one twentieth the same impacts occurring today. With a time horizon of 50 years, the impacts are 
worth one fourth the same impacts occurring today. Therefore, 50 years might be an appropriate 
time horizon if health impact modelling covers such a period.
2.2.1.1.4 Start year 
The three main options for a start year for a damage cost study are the following.
1. Focus on past damage costs, i.e. from some past year up to the present. In this case, the 
number of past years to include must be decided. Given the paucity of data on past health 
impacts, it is not advisable to estimate damage costs before 2000.
2. Focus only on future damage costs, i.e. from the current year. In this case, the number of 
future years to include must be decided.
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3. Estimate both past and future damage costs. In this case, the number of past and future years 
to be included must be decided. 
The first year of the analysis should be entered in the first “year” column of the worksheet, 
and all future years will be updated. Expressing costs in currency values in the present year is 
usually most meaningful for decision-makers.
2.2.1.2 Data on health and health service use
Table 2 gives an overview of the data required to estimate health damage costs. In order to 
estimate health costs, three types of information or data are required: on health, on health 
service use and on economic factors. 
Table 2. Data requirements for estimating health costs
Label Variable (per disease selected)
D1 Health impact of selected disease in terms of number of cases and deaths 
(total)
D2 Health impact of selected disease that is climate sensitive (if different from 
D1) in terms of cases and deaths (total)
D3 Health impact of selected disease that is climate sensitive and attributed to 
climate change in terms of cases and deaths (total)
D4 Health-seeking behaviour
D5 Rate of outpatient visits
D6 Rate of inpatient admissions
D7 Length of inpatient stay
D8 Days off productive activities
D9 Full unit costs of outpatient health care
D10 Full unit costs of inpatient health care
D11 Marginal unit costs of outpatient health care
D12 Marginal unit costs of inpatient health care
D13 Value of productive time loss
D14 Value of life
The health effects of climate change are wide-ranging (Fig. 1). To estimate the costs of damage 
to health, the mortality (deaths) and the number of cases in the study area per year (general) 
are required, as well as those attributable to climate change and other information to allow 
calculation of DALYs.3 Table 3 lists the potential health effects of climate change, building 
on Fig. 1. WHO has prepared guidance for estimating the attributable burden (see annexes). 
In countries that have already assessed the health effects or have undertaken studies, the data 
and information can readily be entered onto the spreadsheet. Countries that have not conducted 
studies or assessments must carry out a health impact assessment, before estimating the health 
costs. 
3  One DALY can be considered one lost year of “healthy” life. The sum of DALYs in a population, or the burden of disease, can be considered 
a measure of the gap between current health status and an ideal health situation in which the entire population lives to an advanced age, free 
of disease and disability.
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Table 3. Example of potential health effects of climate change
Climate 
change 
exposure
Primary social and 
environmental effects
Health effects and vulnerable populations
Increased frequency and intensity of extreme weather events
Heat-waves Direct and indirect 
health effects, through:
reduced crop productivity, 
animal deaths, increased 
food prices, fires
Increased total mortality and 
cause-specific mortality
Increased hospital admissions for all causes, 
in particular respiratory, cardiovascular and 
renal diseases, diabetes, mental health
Primarily the elderly, young children and 
people with pre-existing chronic diseases
Floods Direct and indirect 
health effects, through:
Infrastructure damage, 
interruption of mobility, 
interruption of health care 
provision, relocation
Increased mortality (drowning, 
cardiovascular disease, injuries, other)
Increased morbidity (respiratory, 
infectious diseases, injuries, 
intoxication, mental health, other)
Primarily those living in flood plains, 
the elderly and repair workers
Droughts Direct and indirect 
health effects, through: 
reduced crop productivity, 
more animal deaths, 
pests, relocation, fires
Protein–energy malnutrition; 
micronutrient deficiency
Risk for infectious diseases, inadequate 
water supply and sanitation services, acute 
respiratory infections and measles
Primarily children and women 
Vegetation 
fires
Exposure to toxic 
pollutants and fire 
Infrastructure damage
Deaths, increased numbers of burning injuries, 
asthma, chronic and acute respiratory and 
cardiovascular diseases, mental health 
Primarily young children, pregnant women, the 
elderly, people with pre-existing cardiovascular 
and respiratory diseases and fire-fighters
General increase in temperature, changes in precipitation, other
Glacier melting and 
sea-level rise
Increased risk for floods and breaking down 
of coastal settlements, risks for injuries, 
morbidity and deaths (see floods) 
Altered surface 
water, water quality 
and availability
Changes in frequency of waterborne 
diseases (diarrhoeal diseases, algal 
blooms and poisoning, cholera, others); 
changes in the frequency of foodborne 
diseases (e.g. Salmonella)
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Table 3.  contd
Climate 
change 
exposure
Primary social and 
environmental effects
Health effects and vulnerable populations
Reduced food yields, 
changed food prices 
and availability
Malnutrition and micronutrient 
deficiencies; child development
Ecosystem changes and 
changes in microbial 
ecology (host animals, 
vectors, pathogen 
multiplication)
Changes in the frequency of vector- and 
rodent-borne diseases (e.g. dengue, 
malaria, tick-borne diseases, Leishmania, 
depending on present or potential diseases 
that could appear in the study area)
Changes in air pollutant 
concentrations  
Deaths and morbidity from cardiovascular 
and respiratory diseases
Conflicts and displacement Mental health and potential other risks
Loss of jobs and livelihood Mental health and general capacity 
to finance health services
2.2.1.2.1 Morbidity attributable to climate change (D1a–D3a)
The diseases included should have a clear, quantifiable link to climate change. Up to 10 disease 
categories are available on the Excel worksheets; if more categories are needed, the spreadsheet 
can be extended. The three main categories, with subconditions, are: 
• health impacts of extreme weather events, including heat-waves, cold-waves, floods and 
windstorms;
• respiratory diseases, related to ground-level ozone, particulate matter and allergens; and
• infectious diseases, including vector-borne, waterborne and foodborne diseases.
Disease is then described by incidence or prevalence:
• disease incidence = new cases per year, usually acute health conditions; 
• disease prevalence = cases that tend to last longer or are underlying conditions that are 
never or rarely treated (e.g. malnutrition).
To increase the usefulness of the tool, the user should enter three estimates of incidence and 
prevalence: 
• in D1a, the total health impact (cases) of the selected disease
• in D2a, the total number of cases of climate-sensitive disease
• in D3a, the total number of these cases attributed to climate change.
The evolution of cases should be based on changes foreseen to the current health system 
capacity, income and infrastructure. The data sources and a summary of the methods used to 
arrive at the number of climate-attributed cases should be given in the report. If this information 
is not available, it should be estimated. This can be done ad hoc by using WHO guidance (see 
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Annex 2) or by using available health impact estimates, for instance from countries with similar 
climatic conditions.
 
2.2.1.2.2 Mortality attributable to climate change (D1b–D3b)
The premature deaths entered should be those attributable to climate change. The evolution of 
the number should be based on changes foreseen to the current health system capacity, income 
and infrastructure. The data sources and a summary of the methods used to arrive at the number 
of climate-attributable deaths should be given in the report. If this information is not available, 
it should be estimated. As for morbidity, this can be done ad hoc by using WHO guidance (see 
Annex 2) or health impact estimates from countries with similar climatic conditions. Three 
estimates of mortality must be entered: 
• in D1b, the total health impact (deaths) of the selected disease
• in D2b, the total number of climate-sensitive deaths
• in D3b, the total number of these deaths attributable to climate change.
In countries still undergoing rapid development, it is important to determine whether the future 
disease burden will be reduced by general development within and beyond the health sector. 
Hence, current disease burdens may be lower in the future not because of climate adaptation or 
response measures but due to a strengthened health system and greater resilience to the impacts 
of climate change. This distinction is, however, difficult to make quantitatively.
2.2.1.2.3 DALYs (D1c–D3c)
DALYs are calculated automatically from the numbers of cases and deaths entered in D1 and 
D2, combined with other data, which should be entered on the “inputs” worksheet, as follows: 
• the discount rate (default of 3% per annum provided; Drummond et al., 2005);
• the duration of disability per case, in years, compiled from expert opinion, surveys and the 
literature (including WHO documents);
• the disability weight (loss in quality of life during illness from a perfect health score of 1.0), 
from WHO documents; and
• the average life expectancy of people who die prematurely from each disease (based on the 
average life expectancy in the country) at the average age of death from the given health 
condition. 
Three estimates of DALYs are made automatically in the sheets: 
• in D1c, the total health impact (cases) of the selected disease
• in D2c, the total number of cases of climate-sensitive disease
• in D3c, the total number of these cases attributed to climate change. 
To avoid adding excessive complexity to the spreadsheets, the tool does not require the user to 
add age and sex disaggregation of disease burden. While this approach simplifies the analysis, 
it may result in some avoidable inaccuracies in the final damage cost estimates. For example, 
health care-seeking behaviour, length of treatment, days lost from work and unit costs can vary 
significantly by case and level of the health system, making it hard to enter “average” input 
values for the affected populations. A second disadvantage of not disaggregating health impacts 
by age and sex, and hence damage cost results, is that potential differences in health impact 
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distribution in the population are ignored; hence, response measures may be inappropriate for 
specific groups. If the analyst intends to enter age or sex disaggregation, the following three 
alternatives are proposed.
• List important disaggregation in the 10 spaces provided for health conditions, for example, 
distinguishing between adults and children for diarrhoeal diseases, for which the rates are 
usually specific to age. In this case, the analyst should specify the disaggregation in the 
worksheet (e.g. “cases of diarrhoea, adults”; “cases of diarrhoea, children”).
• Copy a new worksheet for each subset of the population, for example disaggregating 
between men and women or between adults and children. This solution requires an additional 
worksheet for summarizing health costs.
• Reformulate the current worksheet, adding rows to extend the number of possible 
disaggregations.
2.2.1.2.4 Sources of essential health data
Sources of essential health data are listed in Table 4. Further information is given in the annexes.
Table 4. Essential health data and their sources
Epidemiological parameter Data source
Number of cases of any 
particular condition
Number of cases attributed 
to climate change
Epidemiological studies, e.g. 
time series analysis
Health information systems 
Health surveys 
General surveys that include health variables
Health impact analysis (attributable disease)
Number of deaths from any 
particular condition 
Number of deaths attributed 
to climate change
Epidemiological studies, e.g. 
time series analysis
Health information systems 
Health surveys
General surveys that include health variables
Health impact analysis (attributable disease)
Scenario-based analysis
Proportion of cases attributed to 
climate change that are prevented 
by any given intervention
Health intervention studies
Assumptions 
DALYs lost per case or per death Standard methods based on length of disease, 
severity weighting, life expectancy
2.2.1.2.5 Health service use data
Five main types of data on health service use and disease impact are required.
(1) The data on health care-seeking behaviour (D4) entered should reflect the proportion (%) 
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of patients seeking care from each main category of health care provider. A key variable in 
calculating health care costs is the proportion of patients who seek treatment. Some seek 
treatment from formal health providers, while others rely on informal health providers or treat 
themselves. All treatment has a cost, which should be quantified. Disaggregated input data for 
each type of disease may be lacking, and few sources can provide these data. Routine health 
information systems do not collect them, and other national surveys should be consulted.
(2) Outpatient visit rates (D5) are also required. To determine the costs associated with a patient 
seeking treatment, the average number of visits must be known, as some diseases require 
follow-up treatment, while for other diseases the first treatment may not work and the patient 
must return to the same or a different provider for a different type of treatment. The data sources 
on visits per case are, however, limited. Routine health information systems may have such 
information. The default value is 1 visit per case, unless data or arguments exist to modify it to 
another value. In fact, one visit per case is the minimum, as the variable is “Average visits per 
case of disease seeking treatment from a provider”.
(3) To determine the rate of inpatient admissions (D6) the figure needed is the proportion (%) of 
people seeking formal outpatient care who are admitted to hospital. Data from sample hospitals 
can be used, in which the number of outpatients is compared with the number of inpatients by 
disease grouping. These data can be compared with other types of survey data.
(4) The Length of inpatient stay (D7) stay can be accessed from hospital records or from expert 
opinion (e.g. ward nurses). It should reflect the lower level of inpatient facilities (e.g. district 
hospitals), to which most patients are admitted. If more than one level of inpatient care must be 
reflected, additional categories should be added to the sheet.
(5) The average number of days off productive activities (D8) is a key variable. Loss of time 
due to morbidity can cause welfare loss from loss of income or productive work, loss of school 
time and loss of leisure or non-productive activities, which also have a value. It is important to 
base this variable on data rather than assumptions. The number of days of lost productivity does 
not necessarily correspond directly to the length of an episode. People with mild acute disease 
or chronic diseases may work while they are sick, but they may be debilitated—either working 
fewer hours or less efficiently than if they were healthy. People with more severe acute diseases 
(malaria, typhoid, hepatitis) will not work at all during a period of their illness, before they 
feel able to return to their daily activities or their place of work. In both cases, the number of 
full-day equivalents lost from productive activities should be used. Productive time losses can 
also include the time and travel costs of family members, friends and paid carers accompanying 
the sick person to a health facility or collecting medications from a health facility, such as a 
pharmacy. This variable is clearly sensitive to the severity of disease, and severity can vary 
significantly within a single disease category. Hence, it may be worthwhile to distinguish two 
or more categories of high-impact diseases.
2.2.1.2.6 Sources of data on health service use 
Essential data sources are listed in Table 5. Further information is given in the annexes.
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Table 5. Essential data on health services use and their sources
Epidemiological and health 
service parameter
Data sources
Proportion of patients who seek treatment Health surveys
Health service data
Assumption
Outpatient visit rates Published studies 
Health service data (medical records)
Inpatient admission rates Published studies 
Health service data (medical records)
Interview with health providers
Length of inpatient stay Published studies 
Health service data (medical records)
Interview with health providers
Length of illness (for productivity loss) Published studies
Health surveys
Health service data (medical records)
Interview with health providers
Note that use rates may be less than optimal because of unexpressed need for health services. 
Interpretation of damage cost results is therefore clearer if health service availability, such as 
population coverage of primary and secondary health facilities, is recorded separately. 
2.2.1.3 Economic data and their sources
The valuation method used in the tool follows conventional market-based costing techniques, 
with current prices of labour, services and products that are used or affected by the health impact 
(Sugden and Williams, 1978; Pearce and Nash, 1981; Hanley and Spash, 1993). Information is 
required on five economic variables.
2.2.1.3.1 Full unit costs of outpatient health care (D9)
Unit costs should include all aspects of treatment, including fixed costs such as staff and 
medical and non-medical equipment, as well as variable costs, such as supplies, medications 
and laboratory tests. Unit costs should be as specific as possible to each type of disease. As not 
all patients with a particular disease will receive exactly the same treatment (because of non-
availability of medications or laboratory tests or differences in severity that require different 
protocols), the average cost per patient should be estimated. For most diseases, the consultation 
costs at public clinics and hospitals within a country will be similar, with variation mainly in 
the supplies and medications used and, in some instances, diagnostic laboratory tests. For each 
disease, the percentage of patients who receive different types of medication, laboratory tests, 
intravenous drips and referral to higher-level facilities should be assessed.
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For the purposes of economic evaluation, it is important to note that the price of publicly 
subsidized treatments and medications does not represent their full cost to society. For the 
purposes of cost estimation, the cost of unsubsidized, privately purchased goods and services 
is the best. To ensure that the full costs of resources are captured, the prices or tariffs of any 
publicly subsidized services should be adjusted to omit the subsidy element (WHO, 2010b). 
Services at public facilities, such as medication prices, should be compared with those of 
private pharmacies or health care providers. Furthermore, the available unit cost data should be 
assessed for completeness and national representativeness. For example, unit costs from studies 
conducted in tertiary hospitals should not be used when most patients are treated in primary 
facilities.
For patients who buy their medications from private pharmacies, the average prices in those 
pharmacies should be used as the unit cost. The prices of medications are assumed to include 
a mark-up for the cost of pharmacy staff, distribution and transport and a (small) profit. The 
same is true for private shops or stalls (without a qualified pharmacist) at which sick people 
commonly purchase their medications, which tend to be cheaper than at a pharmacy. 
The prices of private health care providers, such as nongovernmental clinics or hospitals, may 
be obtainable from these facilities. Patients’ bills are usually broken down by the treatment they 
received and the unit cost per treatment subtype. Hence, patients’ bills in theory include all the 
services they received. 
For some diseases, unit costs vary by age group. For example, children are more likely to need 
a drip, whereas the dose of medication they require may be lower than for adults. The costs 
should be assessed case-by-case.
For formal health care, which is more likely to require transport to a health care establishment, 
travel costs per return visit are also required. Travel costs include the costs to both the patient 
and any accompanying people, especially for children. The unit cost should reflect the average 
transport cost for people attending any formal health care facility (clinic or hospital). The main 
cash outlays will be for taxi fares and bus tickets. When possible, the fuel cost for patients who 
use their own motorbikes or cars should be estimated and included. The average unit cost should 
reflect that for patients who use a mixture of forms of paid transport and for those who live close 
enough to walk or cycle to the nearest formal facility. Ambulance costs are not included in this 
category and, when possible, should be covered in the costs of health care.
2.2.1.3.2 Full unit costs of inpatient health care (D10)
The same principles apply to inpatient care. The inpatient cost per day should be estimated 
when possible and multiplied by the average length of stay per disease to estimate the total cost 
per admitted patient. When only the cost per admission is available from a study, one can either 
estimate cost per day on the basis of the average length of stay (in days) recorded in the study 
or insert the cost per admission in the “Cost per day” cells, and enter the number “1” in the 
“Average length of stay” cell to avoid multiplying by the average length of stay.
2.2.1.3.3 Marginal unit costs of outpatient (D11) and inpatient (D12) health care
For some budgeting decisions, marginal costs provide useful additional information on the 
immediate financial implications of changes in patient load. The marginal costs of outpatient 
care include additional items used in the care of one patient. Typically, staff, overhead and 
capital or building costs are not affected by the treatment of one additional patient. For example, 
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if a clinic receives and treats 100 patients in a morning, the listed costs would not be affected if 
an additional patient (the 101st) presented for treatment. Medications, supplies and chemicals 
used for laboratory tests and bus fares are, however, all additional costs that at some point 
involve additional cash outlay by the health system or the patient. The treatment of the 101st 
patient would have led to additional use of some of these resources, depending on the condition 
and the availability of diagnostic and treatment options. Therefore, when collecting health care 
unit costs, a breakdown between full and marginal cost should be made when possible.
2.2.1.3.4 Value of productive time loss (D13)
The value of labour time should be based on a nationally representative figure, such as the 
average wage, median wage or GDP per capita. These values are typically available from 
published economic statistics or from relevant government departments. International statistics 
provide standardized GDP measures.4 The annual value should be converted to a daily value on 
the basis of the number of working days per year. 
The fraction of this value to be used for the estimated welfare impact should also be ascertained, 
as potential income foregone may not be a good measure of welfare loss. The value of time has 
been researched most thoroughly in the field of transport economics, in which it was shown 
to vary by travel mode, travel purpose and income (Gwilliam, 1997). The value of time lost 
from productive activities due to illness can be assessed by collecting information on what 
the sick person would have been doing with his or her time. If the person would have been 
working in a remunerated activity, the value of the lost production or income would be recorded 
as the economic loss due to their illness. If the person would have been working in a non-
remunerative activity, the cost of replacing the person would be recorded, approximated by the 
average or minimum wage. If the person would have been enjoying leisure time, a value related 
to suffering from the pain and inconvenience of the sickness and not being able to undertake 
leisure activities would have to be recorded. Given the complex computations required to assess 
comprehensively the economic losses associated with many different foregone activities, some 
studies have applied an average value of productive time lost—30% of the average GDP per 
capita—to represent the overall opportunity cost of sickness time for the entire population 
(Hutton, 2012). This reflects an average for working populations, non-working populations and 
schoolchildren. If the majority of sick people are working, however, this percentage would be 
an underestimate of the value of productive loss.
Financial value depends on the loss of income of those who would have worked for a wage 
or whose own production leads to an income. It requires information on the proportion of sick 
people of working age and the proportion of those who lose income due to illness.
2.2.1.3.5 Value of life (D14)
The economic benefit for society of preventing premature mortality can be estimated by various 
methods. A “value of a statistical life” (VSL) is frequently used, representing the value that a 
given population places on the avoidance of one premature death. The concept is sometimes 
referred to as “value of a prevented fatality”, such as in the literature on transport safety. In 
the VSL, the qualifier “statistical” refers to the fact that the value does not refer to any one 
individual but to a statistical construct. In applying VSL values, it is important to avoid any 
misinterpretation (such as the notion of a price on human life), as the underlying concept of 
VSL is ultimately a society’s willingness to invest in the prevention of premature mortality. 
4 Relevant examples are the databases of world development indicators compiled by the World Bank: http://data.worldbank.org/indicator/
NY.GDP.PCAP.CD.
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Another approach to the value of an avoided fatality is aggregating the income foregone by the 
premature death of an individual, a method known as the “human capital approach”. There are 
several other methods, but the VSL and human capital approach are the most widely used. WHO 
uses VSL in the context of another health valuation tool, the “health economic assessment tool” 
for cycling and walking (WHO Regional Office for Europe, 2008).
The basic method is VSL, with documented estimates of willingness to pay, while the alternative 
method is the “human capital” approach. The VSL method typically gives a higher value than 
the human capital approach. The algorithms are found on the worksheet.
The best estimates of VSL are obtained from well-conducted, relevant studies. When local 
studies are not available, analysts often draw on studies conducted mainly in countries of the 
Organisation for Economic Co-operation and Development. US$ 2 million is a common mid-
range VSL in richer countries, although it varies from around US$ 1 million to US$ 10 million 
(Lindhjem, Analyse and Navrud, 2012).5 Extrapolation is typically made by adjusting for the 
proportional difference between the GDP of two countries.6 Extrapolation therefore requires 
updated GDP values for both the country and the country or countries for which VSL values 
are being extrapolated. VSL values should not be directly extrapolated from richer countries 
to lower-income countries of the European Region. For several reasons, including differences 
in income elasticity and risk perceptions, direct extrapolation is bound to severely affect the 
validity of the VSL.
Estimation of the value of life by the human capital approach requires: the average annual 
income per capita, annual discount rate of future income and income per capita real annual 
growth rate. The latter should be relatively conservative, reflecting expected long-term trends: 
for example, no more than a 5% growth rate, even if current economic growth rates are higher. 
The values should reflect average nationwide values. The cost for society of the premature death 
of an individual goes far beyond foregone economic income, so the human capital approach 
is widely considered to be an underestimate of costs. As it is based on market earnings, it also 
yields particularly low values for people not in the formal labour market, like children and 
retirees (Landefield and Seskin, 1982). 
2.2.1.3.6 Sources of economic data 
Table 6 gives the sources for finding data for estimating the various economic parameters.
In interpreting health cost results, it is important to understand that estimates of mortality carry 
a significantly higher proportion of the cost than health care and morbidity-related productivity; 
hence, the importance of correctly estimating the value of life. Illustrative examples are found 
in economic analyses of other global environmental health impacts (Hutton et al., 2006; Hutton, 
2012) and country environment analyses (World Bank, 2008). 
Any health service inefficiency can lead to an overestimate of true health costs, because observed 
unit costs and hospital length of stay are higher than in an efficiently operating system. In 
contrast, unmet demand for health services can lead to a lower rate of treatment-seeking than 
would be the case if services were more accessible. Also, some cost elements may be omitted, 
such as unpaid inputs (e.g. informal caregivers) and self-treatment, the costs of which may not 
be fully included in health service costing.
5  On the basis of over 900 observations, a study by the Organisation for Economic Co-operation and Development gave mean VSLs for three 
risk types: environment (US$ 8.7 million), health (US$ 4.7 million) and traffic (US$ 6.9 million), in 2005 prices
 6  Multiply the VSL estimate by (the GDP per capita of the target country) ÷ (the GDP per capita of the country with VSL estimates).                             
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Table 6. Essential economic parameters and their data sources 
Economic parameter Data sources
Unit costs of health 
care (D9–D12)
Published literature 
Accounting data
Value of productive 
time (D13)
Proxy such as average wage, median wage, minimum wage 
or GDP per capita, converted to hourly or daily values
Value of premature 
death (D14)
VSL benefits transfera from published meta-analyses, adjusted 
to the country
VSL from country-specific studies
Local estimate of value of life from lost wages (human capital 
approach)
 
a Taking a value from a study in one context and transferring it to another context. Usually, 
when there is a difference in income between settings, the VSL is adjusted by the difference 
in income.
2.2.1.4 Sensitivity analysis 
Given the uncertainty inherent in various data inputs (e.g. estimates of attributable mortality 
and morbidity), it is informative to conduct a sensitivity analysis in order to assess the probable 
range of outputs from the model with different data inputs. To keep the sensitivity analysis 
simple, one- or multiway analyses can be conducted, with extreme scenarios for individual or 
multiple variables together. To conduct a one-way sensitivity analysis, the user should enter 
the high value for a single input variable and then record the results; the same procedure is 
followed for low values for the same input variable. This can be done, for example, with the 
disease or unit cost variables. For the value of life, the value for the human capital approach can 
be selected instead of the VSL value (in “health cost” worksheet, section D14). 
To conduct a multiway sensitivity analysis, the user should enter the high values for several 
input variables together and then record the results; the same procedure is followed for low 
values for the same input variables. The high and low values this produces should be presented 
with the base case results and a conclusion drawn on how robust the estimates are. 
2.2.1.5 Data analysis 
From the data on the costs of mortality, health care and productivity losses, the spreadsheet 
calculates the welfare economic impact of the health damage and the financial impact of the 
damage.
2.2.1.5.1 Full damage costs (D16)
Estimation of full damage costs is handled automatically by the “damage cost” worksheet, 
and the summary figure should be transferred to the “outputs” worksheet (rows 69 and 73) 
for comparison with the adaptation costs. The numbers will reflect the full impact on social 
welfare. Any changes in the number of disaggregations (in D1–D3) or in the cost estimation 
method will therefore require updated algorithms in D15 and D17. Also, to produce graphics 
and summary tables, the analyst should structure the results accordingly. Table 7 shows the 
calculation algorithms used. 
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Table 7. Calculation of full damage costs 
Type of cost Formula
Full health costs = Full health care costs + Health-related productivity costs + 
Premature mortality costs
Full health care costs = Full outpatient costs + Full inpatient costs
Full outpatient costs = Health cases x Proportion of patients seeking outpatient care 
x Number of outpatient visits per patient seeking treatment 
x (Full unit cost of health service per consultation + Full 
patient transport cost per visit + Pharmacy unit cost)
Full inpatient costs = Health cases x Proportion of patients seeking outpatient 
consultation x Hospital admission rate (admissions per 
outpatient) x Average length of hospital admission x (Full 
unit cost of inpatient health service per day + Full patient 
transport cost per visit) 
Health-related 
productivity costs 
= Health cases x Average number of days off productive 
activities x Economic value of a day spent sick
Premature mortality costs = Number of deaths x Value of life
2.2.1.5.2 Marginal (budget) damage costs (D17)
Estimation of financial damage costs is handled automatically by the “damage cost” worksheet, 
and the summary figure should be transferred to the “outputs” worksheet (rows 70 and 74) 
for comparison with the adaptation costs. The numbers will reflect marginal budget impacts 
(covering both households and public budgets). Any changes in the number of disaggregations 
(in D1–D3) or in the cost estimation method will therefore require updated algorithms in D16 
and D18. Also, to produce graphics and summary tables, the analyst should structure the results 
accordingly. Table 8 shows the calculation algorithms used.
2.2.2 Estimating the cost of adaptation
2.2.2.1 Methodological considerations
2.2.2.1.1 Selection of health conditions
If a damage cost study has been conducted, the analyst will have a good indication of the main 
health impacts of climate change in terms of cases and deaths. The damage costs associated 
with the health impacts can guide the choice of the most important health impacts for inclusion 
in the adaptation cost exercise. There are no rules for selecting health impacts that are worthy 
of inclusion in an adaptation plan. To ensure that the main health impacts are covered, all the 
quantified health impacts that account for 90% of deaths or 90% of morbidity might be included. 
This is a two-stage criterion, as mortality and morbidity should be considered separately; for 
example, important health impacts may have low case fatality rates and would be included in 
the costing study because of the large number of cases of illness.
Some health impacts may be included in an adaptation costing which were not included in 
the damage cost study, either because there are no quantified health impacts for the disease or 
because the observed increase in the number of cases is not necessarily linked to climate change. 
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Table 8. Calculation of marginal damage costs 
Type of cost Formula
Marginal health costs = Marginal health care costs + Health-related productivity 
costs
Marginal health care costs = Marginal outpatient costs + Marginal inpatient costs
Marginal outpatient costs = Health cases x Proportion of patients seeking outpatient 
consultation x Number of outpatient visits per patient 
seeking treatment x (Marginal unit cost of health service 
per consultation + Marginal patient transport cost per visit 
+ Pharmacy unit cost)
Marginal inpatient costs = Health cases x Proportion of patients seeking outpatient 
consultation x Hospital admission rate (admissions per 
outpatient) x Average length of hospital admission x 
(Marginal unit cost of inpatient health service per day + 
Marginal patient transport cost per visit)
Health-related productivity 
costs 
= Health cases x Average number of days off productive 
activities x Economic value of a day spent sick
In such cases, the adaptation costs for these health conditions can be included but with statements 
about the uncertainty involved. In the comparison of adaptation costs and damage costs averted, 
the adaptation costs related to these diseases should be removed from the comparison.
2.2.2.1.2 Selection of interventions 
Once the health impacts have been agreed, the interventions that are likely to be needed for a 
rational, affordable response should be planned or simulated. Therefore, the interventions should 
be related to current sector policies, health and other infrastructure, human resource availability 
and probable effectiveness. As the calculation is a projection, any ongoing sector reforms likely 
to affect the interventions selected should be taken into account. The interventions will not 
respond to the actual health impact but will prepare for possible future impacts (i.e. risk).
Other sectors that affect health should also be considered and included in the estimate of 
adaptation costs, depending on the allocation of responsibilities and other activities in the 
country, such as:
• water supply and wastewater service providers: to protect these utilities from extreme 
weather events, to protect the environment from pollution and to provide clean water;
• industry and energy suppliers: to ensure a supply of clean energy and to regulate food safety;
• agriculture in its broadest sense, including land management, forestry and fisheries: to protect 
these resources from extreme weather events (e.g. droughts, floods) and their consequences, 
such as wild-fires, malnutrition and infectious diseases;
• municipal services: to protect municipalities from extreme weather events, support “green” 
transport and energy policies, provide “green” spaces and provide or regulate health services;
• housing and infrastructure: to protect these structures from extreme weather events, such as 
heat-waves and other health risks (infectious, respiratory);
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• meteorological services: to prepare for extreme weather events and hence prevent some of 
the predicted effects;
• emergency services: to prepare and respond to extreme weather events and other health 
emergencies (e.g. outbreaks); and 
• social welfare services: to support low-income households that do not have the financial 
means to pay for adaptive responses.
General adaptation measures that may be required to reduce the health effects of climate change 
and to protect population health7are the following. 
• Integrate consideration of climate change into national and subnational health planning.
• Strengthen primary health care and public health action.
• Build capacity in the health workforce.
• Build climate-resilient infrastructure.
• Conduct advocacy and awareness-raising.
• Strengthen surveillance and early warning for climate-sensitive disease.
Table 9 lists measures required for specific health risks. Neither the preceding list nor this one 
is exhaustive; they should be adjusted on the basis of local and national public health adaptive 
capacity and systems. Annex 1 gives sources of information on adaptation measures that have 
been taken in various WHO regions. 
For the purpose of improved cost presentation, interventions have been classified as being of 
two types: 
•	 The	 first	 not	 specific	 to	 health	 conditions and may benefit a range of health conditions 
related to climate change. Some examples of this type of interventions are:
 ◦ sensitization and advocacy on climate change and health;
 ◦ policy on climate change adaptation;
 ◦ capacity-building, such as training and infrastructure projects; and
 ◦ technical work, such as building an evidence base.
These activities are not motivated by a single health condition. Further activity headings can 
be added when relevant. These costs can either be apportioned across the health conditions 
according to some allocation rule or kept as a separate category.
•	 The	second	type	of	intervention	is	specific	to	health	conditi					ons. Activities and their costs 
are identified to target a single disease or health condition, such as hospital care, vaccination 
or community sensitization, and include health campaigns for a single health issue.
When there are alternative, competing interventions, it is best if the analyst explicitly estimates 
the costs of each but avoids adding the costs. The tool can be adapted to include costing of 
minimum, medium and maximum packages or policy responses. 
7  A public health approach to climate change. In: Implementing the 7 country initiative on protecting health from climate change. Internal 
project document.
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Table 9. Tentative list of measures to be taken in health and other sectors to protect 
population health against specific risks
Health effects 
and vulnerable 
populations (see 
also Table 3)
Interventions in health and other sectors
Extreme weather 
events
• An all-hazards approach, including early warning systems and 
specific threat prevention, preparedness and response plans. 
• Programmes to map risk areas and monitor adverse health outcomes. 
• Generally strengthened implementation of the International Health 
Regulations 2007.
Heat-related 
effects on 
mortality and 
morbidity
• Heat–health action plans, including: urban planning; indoor heat 
reduction measures; early warning; mobilization of social and health 
resources and adjustments to health care; widespread information; 
identification and special attention to vulnerable populations; 
monitoring and evaluation.
Flood-related 
mortality and 
morbidity
• Avoidance of building in flood-prone areas. Flood–health 
prevention plans, including: structural (e.g. physically engineered) 
interventions, such as flood defences, and non-structural (e.g. flood 
preparedness plans) interventions. Identification of vulnerable or 
high-risk populations; early warning systems; evacuation plans and 
planned refuge areas; provision of clean drinking-water and food; 
surveillance and monitoring of health impacts; provision of health 
care to ill people; targeted risk communication and recovery and 
rehabilitation of flooded houses and health infrastructure. 
Drought-related 
deaths and 
morbidity
• Prevention of health effects, including early warning; food, water and 
nutrition provision; migration areas, targeted risk communication
• International mobilization of resources.
Deaths and 
morbidity related 
to vegetation fires
• Early warning; specific health education measures (e.g. masks, 
staying indoors); health system preparedness planning; evacuation 
plans.
Increased risk 
for infectious 
disease outbreaks
• Generally strengthened implementation of the International Health 
Regulations 2007.
Changed 
frequency of 
waterborne 
diseases 
• Regulations to control water- and foodborne diseases and 
contaminants; programmes to increase access to and use of safe 
water and improved sanitation; surveillance and monitoring for 
water- and foodborne diseases; vaccination; education on food 
handling and safety; water quality regulations; watershed protection 
laws, small-scale water projects.
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Table 9. contd
Health effects 
and vulnerable 
populations (see 
also Table 3)
Interventions in health and other sectors
Changes in 
the frequency 
of foodborne 
diseases 
• Regulations to control foodborne diseases and contaminants; 
food and nutrition action plans, surveillance and monitoring for 
foodborne diseases; education on food handling and safety.
Changes in 
the frequency 
of vector- and 
rodent-borne 
diseases 
• Early warning systems; surveillance and monitoring for malaria and 
other vector-borne and zoonotic diseases; maternal and child health 
programmes, including vaccination campaigns; integrated vector 
management and environmental hygiene; education for individuals, 
communities and health-care workers for identifying and treating 
diseases.
Health effects 
related to air 
quality 
• Strengthened air quality monitoring; programmes to alert the 
population and health-care providers on days with poor air quality 
or fires and appropriate personal protection measures to be taken; 
education for individuals, communities and health-care workers on 
the risks of poor air quality and appropriate protection measures to 
be taken; air quality regulations to control emissions of contaminants 
from traffic, industry and other sources.
Malnutrition and 
micronutrient 
deficiencies
• Monitoring programmes for malnutrition in vulnerable populations; 
programmes to support local food production and sustainable 
food sources; emergency response plans to increase food security; 
nutrition education for individuals and communities.
Mental health 
and possible 
other risks
• Mental health programmes, counselling.
General household 
ability to finance 
health care
• Programmes to protect financially weak families and households.
2.2.2.1.3 Expected health impact 
The numbers of cases and deaths likely to be averted (that is, the effectiveness of adaptation) 
should be estimated on the basis of the health burdens and the selected interventions, as well as 
how many cases are correctly treated in a timely fashion. 
In the simplest of cases, the assumption in the tool is that all mortality and morbidity could 
be avoided by adaptation. If that is considered unrealistic, successive iterations of the tool 
could be run in a sensitivity analysis, for instance assuming that adaptation can prevent 25%, 
50% or 75% of all climate–change–related mortality and morbidity. Other proportions can be 
chosen, depending on the availability of data to support the choice, e.g. if a heat–health action 
plan has been running long enough to evaluate its effectiveness in a time series analysis. The 
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proportion chosen will affect the efficiency ratio, thus giving the analyst and end users a broader 
understanding of the magnitude of costs and benefits in different scenarios. 
Note that the averted health impact will be not only that of the climate change-attributed burden 
but also the entire health impact. Estimating the health impact averted is an important step 
towards an economic evaluation, such as a cost–effectiveness or cost–benefit analysis. The 
analyst is referred to other guidelines for conducting economic evaluations (Tan-Torres Edejer 
et al., 2003; Organisation for Economic Co-operation and Development, 2006).
2.2.2.1.4 Level of analysis
The worksheets are flexible enough to be applied at any level of administration, such as district, 
region, oblast or country. The relevant parts of the worksheets can even be applied at health 
facility level, such as a hospital. If a single analyst does not have access to the full range of 
policies, interventions and costs, the worksheet can be broken up and distributed to different 
agencies to fill in and then reassembled.
2.2.2.1.5 Level of detail
To increase the accuracy and reliability of the costing exercise, the worksheets require 
specification of activities and hence the quantity of resources or services required, with unit 
prices. This enables the analyst or a third party to rerun the calculations when quantities or 
prices change or to conduct scenario and sensitivity analyses for risk management. As many 
stakeholders are involved in health adaptation, those responsible for implementation and 
financing are recorded with the activities and costing data. Adaptation cost estimates are made 
for different health conditions and implementation agents, as there may be competition for 
budget provision. 
While the worksheets are currently not designed to provide a breakdown of subsector activities, 
which would help planning at the sector level, adjustments can be made. For example, it may 
be useful to know the type of service (preventive, curative, palliative) or the level of service 
(primary, secondary, tertiary, emergency) in the health system. For this, columns can be added 
with subservice types. Similarly, the costs of specific resources (e.g. staff, transport, overheads, 
equipment, medicines) can be shown, from the components of unit costs of different services. 
2.2.2.1.6 Cost disaggregation
As stated in the introduction, a selection of cost disaggregations will allow use of the results by 
a range of stakeholders for different purposes. The following are considered important. 
•	 Distinguish	 financial	 costs	 from	 economic	 ones. Financial cost figures show how much 
money must be raised from government budgets, donors or beneficiaries of the programmes, 
such as households. Economic costs summate the financial and non-financial costs, non-
financial costs being resources that have an opportunity cost but that are not paid for in cash 
(e.g. volunteer time) or are already paid for and should be used for a different purpose (such 
as government staff and buildings). The inclusion of non-financial costs recognizes the fact 
that few resources are truly free, and resources usually have alternative uses, which justifies 
estimation of “opportunity cost”.
•	 Distinguish costs by who pays for the service provided. For costs met by government 
agencies, it is necessary to know to which ministry the funds should be channelled. For costs 
met by beneficiaries, an appropriate charging mechanism should be set up. To protect the 
poor and vulnerable groups, the mechanism may involve reducing the burden of payment, 
such as a targeted subsidy or a cross-subsidy from other services.
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•	 Distinguish when a cost has to be paid. Not all costs have to be paid now; hence, for 
planning purposes, it is necessary to know when budgets have to be mobilized. Because of 
uncertainty in health impacts, responses and their costs in the longer term, a 10-year time 
horizon was selected for this costing study. Future costs are discounted to the present value 
at the selected discount rate. Costs are disaggregated, whether they refer to investments 
(which have to be paid at the start of a programme but have a lifetime of more than 1 year) 
or recurrent items, such as routine service provision, operations and maintenance. As some 
activities may be implemented for a limited period, the worksheet requests the analyst to 
distinguish when within the 10-year period a specific activity is expected to be carried out.
2.2.2.1.7 Period of analysis 
The investment for some cost items lasts more than 1 year. The expected duration of investment 
must be recorded so that planning agencies know approximately when a re-investment is needed. 
It also allows calculation of annual equivalent costs (similar to a depreciation calculation in 
accounting). Some activities may have limited life span, as they are part of other activities or 
are expected to be replaced by other policies or technologies in the future. The starting and end 
year can be entered here. For activities that are required each year, a start date “1” and end date 
“10” are entered.
2.2.2.2 Data input
Table 10 gives an overview of the data required to estimate health damage costs.
Table 10. Overview of data requirements to estimate adaptation costs
Label For each adaptation action (A1), the following data are required
A2 Resource use actions
A3 Responsible implementing agent
A4 Percentage of final cost incurred by different agents
A5 Actual resource use and unit cost
A6 Economic cost
A7 Financial cost
A8 Period of validity
A9 Period undertaken
2.2.2.2.1 Adaptation actions (A1)
Adaptation actions are classified as targeted at a single health condition (e.g. action to prevent 
malaria) or a general one, covering more than one health condition, such as health promotion 
or disease surveillance. For each health condition targeted with specific activities, a different 
“Adaptation specific” worksheet should be filled out. General actions that cover more than one 
health condition should be entered on the “Adaptation general” worksheet. 
2.2.2.2.2 Resource use actions (A2)
Several actions may be recorded under a given activity. The purpose of the “action” description 
is to provide the level of detail required for costing. When there is more than one type of 
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resource use for a single action, additional rows on resource use should be added under that 
action. For example:
Activity: strengthened health services to treat additional cases in a timely fashion
 Action 1: outpatient services provided
  Resource use 1: diagnostic care (e.g. laboratory tests)
  Resource use 2: consultation with professional provider
 Action 2: inpatient services provided
  Resource use 1: appropriate medications
  Resource use 2: inpatient stay 
It is important that it be possible to identify an appropriate “unit of measurement” and an 
associated unit cost at the level of “resource use” (see A5). Further disaggregation of activities 
might require significantly more data. For example it is easier to derive the unit cost of a hospital 
service, such as an outpatient visit, from the literature than to estimate the costs accurately on 
the worksheet from all the service and resource components (e.g. staff, equipment, materials, 
laboratory).
2.2.2.2.3 Responsible implementing agent (A3)
For the purposes of cost presentation, the analyst should pre-define the main actors and 
institutions that will implement the activity. There may be only two or three responsible agencies 
for a specific health condition. On the worksheet, the agency should be identified at its highest 
unit, such as the line ministry in the case of government. Other examples include a water utility 
or an inter-ministerial partnership. The responsible departments or units within the line ministry 
can be identified in the description of activities in separate documentation (i.e. the report). 
2.2.2.2.4 Percentage of final cost incurred by different agents (A4)
The data entered in these cells should reflect who pays what percentage of the final service. 
The cells should add up to 100%, and the values should be explained in separate sheets. When 
the “Other” column is used, a footnote should be added stating who bears this cost. This is 
necessary for later calculation of the total costs to be financed by each sector or agency.
These data do not reflect the actual mechanism by which costs are financed, such as an up-front 
subsidy that is later recovered in service tariffs. It also does not show the role of foreign donors 
in lending money to governments, which is later paid back. Such transfers of money can be 
recorded separately to aid interpretation.
2.2.2.2.5 Actual resource use and unit cost (A5)
This section consists of four variables.
• “Units of measurement” show the units in which data are shown in the following column. 
The units could be e.g. “inpatient days”, “trained personnel”, “laboratory tests” or “vehicle 
kilometres”.
• “Units” are the numbers of units consumed in this activity.
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• “Full unit price” reflects the full cost of the activity. When possible, actual production 
cost should be used rather than the prices charged to the service user. Some prices may be 
underestimates of the true cost of producing the service (e.g. a public health provider that 
charges tariffs below full cost), while other prices may be overestimates of the true cost of 
producing the service (e.g. high profits of a private provider). When unit cost studies were 
conducted before or after the base year, adjustments should be made.7
• “Marginal cost” includes resource uses that lead to an additional cost. For health services, 
for example, such costs are those for treating an additional patient or requiring an outlay in 
money (cash or credit). For outpatient care, they include the cost of medicines and supplies 
used by the patient. In other words, equipment and health personnel are usually not included 
in financial cost; the price paid should be used. All of the costs for new investments that 
must be made to increase capacity, including human resources, are counted as financial 
costs.
2.2.2.2.6 Total economic cost (A6)
These columns contain multiples of the economic unit price and quantity consumed. The result 
is presented in local currency units (LCUs).
2.2.2.2.7 Total financial cost (A7)
These columns present multiples of the financial unit price and quantity consumed. The result 
is presented in (LCUs).
2.2.2.2.8 Lifespan of investment (A8)
For some cost items, the investment lasts more than 1 year. It is important to record the expected 
duration of investment so that planning agencies know approximately when a re-investment 
is required and to enable calculation of annual equivalent costs (similar to a depreciation 
calculation in accounting).
2.2.2.2.9 Period of activity (A9)
Some activities may be implemented over a limited time; some may precede others or are to 
be replaced by different policies or technologies at some point. The starting and end years can 
be entered here. For activities that are required every year, the start date “1” and end date “10” 
are entered. Ten years is proposed as the maximum number of years for which policy-makers 
can plan future activities, given the significant degree of uncertainty in many variables after 10 
years. 
2.2.2.3 Data analysis 
For the sake of simplicity, sensitivity analysis is not built into the tool. A sensitivity analysis 
can, however, be conducted by entering alternative input values and assessing the effect on the 
output. Alternative input values can be chosen on the basis of the available data, or a variation 
can be proposed by the user. This analysis can be conducted at the discretion of the user.
7 Multiply the inflation rate for the years between the cost data and the baseline year. For example: if the baseline year is 2008 and cost data 
are available for 2004, the cost value is multiplied by the inflation rate for each of the four intervening years. Likewise, if the base year is 
before the year of the available unit cost data, then unit costs should be adjusted downwards.              
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The purpose of the summary table is to estimate the costs for different government sectors (line 
ministries) over 10 years. An example table is presented in Table 11. Financial and economic 
costs are filled in separately in LCUs (see “output” worksheet). The private sector is not 
represented, as it operates on a cost recovery basis and hence either government or households 
pay for services. When donors or nongovernmental organizations are present, their activities 
can be represented separately on the worksheet. The sheets allow different types of presentation, 
such as by health condition, but these are not the focus of the summary presentation.
Table 11. Proposed final presentation of adaptation costs
Cost type and payee Total cost per year1 2 3 4 5 6 7 8 9 10 Total Present value
Annual recurrent costs             
 Sector 1             
 Sector 2             
 Sector 3             
 Sector 4             
 Households             
 Total             
Investment costs             
 Sector 1             
 Sector 2             
 Sector 3             
 Sector 4             
 Households             
 Total             
2.3 Step 3. Comparing the costs and benefits of adaptation measures
When both climate-attributed health costs and adaptation costs have been estimated, the 
foundations have been laid for a crude cost–benefit assessment. Whatever adaptation measures 
are taken, however, they are unlikely to avert the full health costs, and there will therefore be 
residual costs. The residual costs are calculated as follows:
Residual costs = Total health costs attributed to climate change – 
Health costs that could be averted by adaptation measures
The health costs that can be averted by adaptation measures should be estimated by assessing the 
reduction in the numbers of cases and deaths that will result from the measures. It is simplest to 
apply a proportional reduction in health impact (cases and deaths) based on either the published 
literature, if available, or informed judgement.
The amount of resources invested in an adaptive measure (intervention “x”) depends on the 
reductions in health (and other) costs that can be bought with the measure. Efficiency ratios can 
be calculated from the collected data:
Benefit–cost ratio = Averted damage costs (intervention x): Adaptation costs (intervention x)
Three cost–effectiveness ratios can be calculated:
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Cost per case averted = Adaptation costs (intervention x): Cases averted (intervention x)
Cost per death averted = Adaptation costs (intervention x): Deaths averted (intervention x)
Cost per DALY averted = Adaptation costs (intervention x): DALYs averted (intervention x)
2.4 Step 4. Presenting results
The results derived with the tool can be presented in various ways, depending on the target 
audience and communication needs. This section provides some examples of how data can 
be presented, reflecting for example the health damage and adaptation costs of heat and heat-
waves at national level. 
2.4.1 Damage costs
After having calculated the number of deaths or cases attributable to climate change, averaged 
over the period assessed, conventional economic methods can be used to value premature death, 
health-related productive time losses and health care costs. Fig. 5 shows an example of those 
costs attributed to climate change, which can be translated into total national annual costs as a 
percentage of GDP (Fig. 6). 
Fig. 5. Costs of cardiovascular and respiratory diseases attributed to climate change 
(through heat waves), over a 5-year period 
Note. LCU: local currency units.
On the one hand, because of the comparatively high value of a statistical life, premature 
death accounts for over 99% of the total costs, at an average of 72 million LCU per year. On 
the other hand, the health care cost, which is close to 600 000 LCU per year, constitutes an 
important monetary cost to the health system. Similarly, although productivity losses may seem 
comparatively small, they can provide solid arguments in advocacy and policy promotion.
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Fig. 6. Damage cost of climate-change-attributed health effects of heat waves as percentage 
of GDP
2.4.2 Adaptation costs
Preventing the health effects of heat-waves requires a series of actions. Optimally, a country 
prone to hot spells should have a full heat–health action plan. Minimum measures range from 
early warnings to outreach and risk communication and investing in and mobilizing health 
and social services. Costs are incurred in a variety of ways. Fig. 7 gives an example of annual 
recurrent costs, at close to 3 million LCU per year. Over half of these costs fall on support 
agencies, and the rest are divided between health agencies and other national agencies. 
Investment costs such as infrastructure, equipment and training are important for effective 
health preparedness and response. These are different in every country. In this example, the 
main one-off investment is made by the ministry of health, and social infrastructure and lesser 
investments by local governments (Fig. 8). These costs include energy efficiency measures, 
air-conditioning and water fountains in hospitals and nursing homes, and communication and 
awareness-raising for medical staff and the general public. 
Fig. 7. Annual recurrent costs of adaptation measures to mitigate health risks due to heat-
waves resulting from climate change
34
Fig. 8. One-off investment costs of adaptation measures to mitigate health risks due to 
heat-waves resulting from climate change
Damage and adaptation costs can be compared at the end of the costing exercise. In this example, 
it is possible to compare the damage costs of the increase in disease cases and deaths that was 
not averted with the costs of adaptation and, it is expected, a partial reduction in the health 
impact. If the adaptation cost is estimated at 3 million LCU annually plus 90 million LCU 
investment costs, and if investments are expected to last 10 years (a conservative assumption), 
the total annualized cost will be 12 million LCU. When compared with the total damage costs 
in the years considered of around 170 million LCU per year, the adaptation costs appear to 
be relatively small. However, the analyst must always acknowledge the uncertainty in the 
proportion of disease cases and deaths attributed to climate change and how many could be 
averted by the adaptation measures. Hence, it is difficult to make full cost–benefit comparisons. 
3. Afterword
This toolkit and the accompanying spreadsheet are intended to support efforts by Member 
States and policy-makers to plan and implement climate change adaptation policies. Advocates 
and citizens are also encouraged to use it, with other tools made available by WHO (see 
Annex 1). Calculation of the health costs of climate change can provide overall estimates of 
the economic magnitude of the problem, and estimates of adaptation costs illustrate the relative 
affordability of mitigating the health impacts of climate change. While health impacts cannot 
be fully represented in economic terms, many stakeholders respond more proactively when 
presented with climate change impacts in economic language. Furthermore, credible estimates 
of adaptation costs provide a basis for budgeting as well as assessing value for money. 
Like other decision support aides, this tool is open to improvements, and feedback from users 
will be used to revise subsequent versions. Ultimately, the outputs from this toolkit will represent 
only one of several inputs to be considered in decision-making and policy cycles. By making 
explicit the economic consequences of the health impacts of climate change, planners, policy-
makers and other actors can further strengthen the case for early adaptation.
WHO offers both on-site and long-distance training on how to use and implement the tool. To 
make a request, please send an e-mail to climatechange@ecehbonn.euro.who.int.
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5. Glossary8
Adaptation*
Initiatives and measures to reduce the vulnerability of natural and human systems against actual or expected 
climate change effects. Various types of adaptation exist, e.g. anticipatory and reactive, private and public, and 
autonomous and planned. Examples are raising river or coastal dikes and substitution of more temperature-shock 
resistant plants for sensitive ones.
Adaptation benefits*
The avoided damage costs or the accrued benefits following the adoption and implementation of adaptation 
measures.
Adaptation costs*
Costs of planning, preparing for, facilitating and implementing adaptation measures, including transition costs
Benefit–cost ratio+
A benefit–cost ratio is an indicator used in the formal discipline of cost–benefit analysis to summarize the overall 
value for money of a project or proposal. A benefit–cost ratio is the ratio of the benefits of a project or proposal, 
expressed in monetary terms, relative to its costs, also expressed in monetary terms. All benefits and costs should 
be expressed in discounted present values. A benefit–cost ratio takes into account the amount of monetary gain 
realized by performing a project versus the amount it costs to execute the project. The higher the benefit–cost ratio, 
the better the investment. A general rule of thumb is that the project is a good investment if the benefit is higher 
than the cost.
Climate change*
Climate change refers to a change in the state of the climate that can be identified (e.g. by statistical tests) by 
changes in the mean and/or the variability of its properties and that persists for an extended period, typically 
decades or longer. Climate change may be due to natural internal processes or external forcing or to persistent 
anthropogenic changes in the composition of the atmosphere or in land use. Note that the UNFCCC, in its Article 
1, defines climate change as: “a change of climate which is attributed directly or indirectly to human activity that 
alters the composition of the global atmosphere and which is in addition to natural climate variability observed 
over comparable time periods”. The UNFCCC thus makes a distinction between climate change attributable to 
human activities that are altering the atmospheric composition and climate variation attributable to natural causes. 
Climate scenario*
A plausible and often simplified representation of future climate, based on an internally consistent set of 
climatological relationships that has been constructed for explicit use in investigating the potential consequences 
of anthropogenic climate change, often serving as input to impact models. Climate projections often serve as the 
raw material for constructing climate scenarios, but climate scenarios usually require additional information, such 
as about the observed current climate. A climate change scenario is one that shows the difference between a climate 
scenario and the current climate.
Cost*
The consumption of resources, such as labour time, capital, materials and fuels, as a consequence of an action. In 
economics, all resources are valued at their opportunity cost, which is the value of the most valuable alternative use 
of the resources. Costs are defined in a variety of ways and under a variety of assumptions that affect their value. 
Cost types include: administrative costs, damage costs (to ecosystems, people and economies due to negative 
effects of climate change) and implementation costs of changing existing rules and regulation, capacity-building, 
information, training and education, etc. Private costs are carried by individuals, companies or other private entities 
that undertake the action, whereas social costs include also the external costs on the environment and on society as 
a whole. The negative of costs is benefits	(also sometimes called negative costs). Costs minus benefits are net costs.
Cost–benefit analysis+
A cost–benefit analysis is a systematic process for calculating and comparing the benefits and costs of a project, 
decision or government policy (hereafter, “project”). Cost–benefit analysis has two purposes: (1) to determine if 
a project is a sound investment or decision (justification or feasibility), and (2) to provide a basis for comparing 
8 The two main sources used were the glossary of the IPCC Fourth assessment report (*) and the report of the WHO Regional 
Office for Europe (2013) Towards a European strategy for environmental health economics (+). 
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projects. It involves comparing the total expected cost of each option against the total expected benefits, to see 
whether the benefits outweigh the costs and by how much. In cost–benefit analysis, benefits and costs are expressed 
in monetary terms and are adjusted for the time value of money, so that all flows of benefits and of project costs 
over time (which tend to occur at different times) are expressed on a common basis in terms of their “net present 
value”. The objective of a researcher conducting a cost–benefit analysis is to quantify in monetary terms every 
possible aspect or attribute (risk, quality, quantity, equality, utility, etc.) that has a cost or benefit as a consequence 
of the decision. This monetary quantification can be very difficult and controversial. 
Cost–effectiveness analysis+
Cost–effectiveness analysis is a form of economic analysis for comparing the relative costs and outcomes (effects) 
of two or more courses of action. Cost–effectiveness analysis is distinct from cost–benefit analysis, which assigns 
a monetary value to the measure of effect. Cost–effectiveness analysis is often used in the field of health services, 
where it may be inappropriate to monetize health effect. Typically, cost–effectiveness is expressed in terms of a 
ratio, in which the denominator is a gain in health due to a measure (years of life, premature births averted, sight-
years gained), and the numerator is the cost associated with the health gain.
Cost–utility analysis+
In health economics, the purpose of cost–utility analysis is to estimate the ratio between the cost of a health-related 
intervention and the benefit it produces in terms of the number of years lived in full health by the beneficiary. 
Hence, it can be considered a special case of cost–effectiveness analysis, and the two terms are often used 
interchangeably. Cost is measured in monetary units. Benefit should be expressed in a way that gives quantitative 
values to health states that are considered less preferable to full health. Unlike cost–benefit analysis, the benefits 
need not be expressed in monetary terms. Usually, they are expressed in DALYs, quality-adjusted life years or 
healthy life years. Putting a price tag on the health indicator effectively changes this type of analysis into a cost–
benefit analysis. 
Disability-adjusted life-year+
The disability-adjusted life year (DALY) is a measure of overall disease burden, expressed as the number of years 
lost due to ill health, disability or early death. Mortality and morbidity are combined into a single, common metric. 
Health liabilities have hitherto been expressed by one measure: (expected or average number of) “years of life lost” 
(YLL); however, this measure does not take into account the impact of disability, which can be expressed as “years 
lived with disability” (YLD). DALYs are calculated by taking the sum of these two components in the formula: 
DALY = YLL + YLD. The DALY relies on acceptance that the most appropriate measure of the effects of chronic 
illness is time—both time lost due to premature death and time spent disabled by disease. One DALY, therefore, 
is equal to 1 year of healthy life lost. Japanese life expectancy statistics are used as the standard for measuring 
premature death, as the Japanese have the longest life expectancy. The study of global burden of disease 2001–
2002 counted life-years equally, but the 1990 and 2004 studies used the formula W = 0.1658 Y e–0.04 Y, where Y is the 
age at which the year is lived, and W is the value assigned to it relative to an average value of 1. In these studies, 
future years were discounted at a 3% rate, so that a weighted year of life saved next year is worth 97% of a year 
of life saved this year. The effects of the interplay between life expectancy and years lost, discounting and social 
weighting are complex, depending on the severity and duration of illness. For example, the parameters used in the 
1990 study generally give more weight to deaths in any year before the age 39 than afterwards, with the death of a 
newborn weighted at 33 DALYs and the death of someone aged 5–20 years weighted at approximately 36 DALYs.
Discounting*
A mathematical operation in which monetary (or other) amounts received or expended at different times (years) 
are made comparable over time. The operator uses a fixed or possibly time-varying discount rate (> 0) from year 
to year that makes future value worth less today. In a descriptive discounting approach, one accepts the discount 
rates that people (savers and investors) actually apply in their day-to-day decisions (private discount rate). In a 
prescriptive (ethical or normative) discounting approach, the discount rate is fixed from a social perspective, e.g. 
based on an ethical judgement about the interests of future generations (social discount rate).
Gross domestic product+
Gross domestic product (GDP) is the market value of all officially recognized final goods and services produced 
within a country in a given period (usually a calendar year). GDP can be determined in three ways, all of 
which should, in principle, give the same result: the product (or output) approach, the income approach and the 
expenditure approach. In the expenditure method, GDP = private consumption + gross investment + government 
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spending + (exports – imports). The gross domestic Income is the total income received by all sectors of an 
economy in a nation. It includes the sum of all wages, profits and taxes, minus subsidies. As all income is derived 
from production (including the production of services), the gross domestic income of a country should be exactly 
equal to its GDP. Nevertheless, the listed figures are different in practice, as they are calculated in different ways. 
This difference is known as the “statistical discrepancy”. GDP per capita is deducted by dividing the GDP by the 
population of the country.
Human capital approach+
Before the concept of willingness to pay became widely accepted by economists as the appropriate evaluation 
method, the human capital approach was the main procedure used to appraise the social value of a lost life. In this 
approach the “value of life” is the value of the individual’s market productivity, assumed to be reflected by the 
individual’s earnings. The human capital is calculated as the individual’s present value of future expected earnings. 
The approach has two major drawbacks: it assigns a zero value to non-market production, implying that e.g. 
unemployed and retired persons have a value equal to zero; and it does not reflect individual preferences for safety.
Health impact assessment+
A health impact assessment is defined as “a combination of procedures, methods and tools by which a policy, 
programme or project may be judged as to its potential effects on the health of a population, and the distribution 
of those effects within the population”. The aim of a health impact assessment is to maximize the positive health 
impacts and minimize the negative health impacts of proposed policies, programmes or projects. The procedures 
for such assessments are similar to those for other forms, such as environmental and social impact assessments. The 
main objective of health impact assessment is to apply existing knowledge and evidence about health impacts to 
specific social and community contexts, to make evidence-based recommendations as a basis for decision-making 
in order to protect and improve community health and well-being. Because of financial and time constraints, health 
impact assessments do not generally involve new research or the generation of original scientific knowledge; 
however, the findings of these assessments, especially when they have been monitored and evaluated over time, 
can be used as a basis for other health impact assessments in similar contexts. The recommendations may focus on 
both the design and operational aspects of a proposal.
Market exchange rate*
The market exchange rate is the rate at which foreign currencies are exchanged. Most economies post such rates 
daily, and they vary little across exchanges. In some developing economies, official and black-market rates may 
differ significantly, and the market exchange rate is difficult to define.
Morbidity*
Rate of occurrence of disease or other health disorder within a population, taking into account age. Morbidity 
indicators include the incidence and prevalence of chronic disease, rates of hospitalization, primary care 
consultation rates, disability days (days of absence from work) and prevalence of symptoms.
Mortality*
Rate of occurrence of death within a population. Calculation of mortality takes into account age-specific death 
rates and can thus yield measures of life expectancy and the extent of premature death.
Net present value+
Net present value is the value of future (or past) payment(s) in current currency. The discount rate is the defining 
factor. An income of US$ 300 a year for 3 years starting today has a net present value of US$ 857.82 if the discount 
rate is 5%: year 1 (today); 300/(1 + 0.05)^0 + year 2; 300/(1 + 0.05)^1 + year 3; 300/(1 + 0.05)^2 = 300 + 285.71 
+ 272.11 = US$ 857.82. The further the payment is into the future, the less is its value today. This effect increases 
with a higher discount rate and vice versa. If the discount rate is 0%, a US$ 300 payment is worth as much today 
as it would be if it were received in 200 years. If the discount rate is set as negative (e.g. –1%), the US$ 300 in 200 
years would be worth much more than if it were received today. 
Non-market impacts*
Impacts that affect ecosystems or human welfare but that are not easily expressed in monetary terms, such as an 
increased risk for premature death or an increase in the number of people at risk for hunger. 
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Social discount rate+
The social discount rate is a measure used to guide choices regarding the value of diverting funds to social projects. 
It is defined as “the appropriate value of r to use in computing present discount value for social investments”. 
Determining this rate is not always easy and can result in discrepancies in the true net benefit to certain projects, 
plans and policies. It is the key input into calculating net present value. The social discount rate is directly 
analogous to concepts used in corporate finance, such as the hurdle rate or the project appropriate discount rate, 
so the calculations are identical. The benefit or cost per US$ can be calculated from: (1/(1 + r)^t), where r equals 
the social discount rate and t equals time. For benefits or costs that have no end, the rate is just (1/r). The social 
discount rate is a reflection of a society’s relative valuation of today’s well-being versus well-being in the future. 
Appropriate selection of a social discount rate is crucial for cost–benefit analysis and has important implications 
for resource allocation. Social discount rates very widely, developed nations typically applying a lower rate (3–
7%) than developing nations (8–15%). 
Value of a statistical life+
In social and political sciences, the VSL is the marginal cost of death prevention in a certain class of circumstances. 
It is therefore a statistical term for the cost of reducing the (average) number of deaths by one. In industrial nations, 
the justice system considers a human life “priceless”, thus illegalizing any form of slavery; i.e. humans cannot 
be bought for any price. With a limited supply of resources and infrastructural capital (e.g. ambulances) or skills, 
however, it is impossible to save every life, so some trade-off must be made. Furthermore, this argumentation 
neglects the statistical context of the term: it is not commonly attached to the lives of individuals or used to 
compare the value of one person’s life to that of another. It is used mainly in the context of saving lives as opposed 
to taking lives or “producing” lives. The VSL is the value that an individual places on a marginal change in his or 
her likelihood of death. It is thus different from the value of an actual life, as it is the value placed on changes in 
the likelihood of death, not the price someone would pay to avoid certain death. Developing markets have smaller 
VSLs. The VSL also decreases with age. 
Willingness to pay+
Used in valuation techniques to determine “How large a lump sum of cash would you be willing to pay to not 
have contaminated drinking-water?” or “How large a lump sum of cash would you be willing to pay to have clean 
drinking-water?” A transaction occurs when willingness to pay exceeds the market price. Unlike the willingness to 
accept approach, willingness to pay is constrained by an individual’s wealth. For example, a person’s willingness 
to pay to stop ending his or her own life can only be as high as his or her wealth, while the willingness to accept 
payment to end one’s life would be extremely high, perhaps approaching infinity.
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Annex 1. Resources for assessing health impacts, vulnerability and 
adaptation to climate change
WHO has been providing leadership and guidance on prevention of the health effects of climate 
change ever since it was identified as a public health threat by the scientific community. WHO 
has therefore published several documents and tools to assess health impacts and design 
health-protective climate change adaptation. These resources can be used by Member States 
in conjunction with the present one as support for analysing their adaptation efforts. Especially 
relevant resources are the following.
• WHO Regional Office for Europe (2003), which provides an overview of climate change 
risks for health and adaptation strategies;
• Campbell-Lendrum D, Woodruff R (2007), which provides guidance for estimating the 
health impacts of climate change, gives specific health outcomes as examples (temperature-
related deaths, deaths and injuries from coastal and inland flooding, malaria and diarrhoeal 
disease) but can be used for any climate-sensitive outcome; 
• Pan American Health Organization (2011), which provides a set of steps for assessing current 
health vulnerability to climate change and adaptation status, as well as future adaptation 
needs; and 
• European Centre for Disease Control (2010), a handbook that provides a method for assessing 
national vulnerability to, impact of and adaptation to climate change and communicable 
diseases. 
Training materials 
WHO conducts capacity-building through seminars in Member States and by issuing training 
material. Some of these materials can be found on the WHO headquarters web site (http://www.
who.int/globalchange/training/en/) and at WHO (2008a).
• The WHO Regional Office for Europe offers a range of training sessions on request (contact 
menneb@who.int). Further information is available online (http://www.euro.who.int/
climate change).
• A training course for public health professionals on protecting health from climate 
change is available in South-East Asia (http://www.who.int/globalchange/training/health_
professionals/en/index.html).
• An atlas of health and climate is available on the WHO headquarters web site (http://www.
who.int/globalchange/publications/atlas/en/index.html).
• WHO has published a training manual, Heat waves, floods, and health impacts of climate 
change: training manual for city health officials, which is available on the WHO headquarters 
web site (http://web.wkc.who.int/projects/uhe/heatw/).
General United Nations training resources on climate change are available from the United 
Nations Institute for Training and Research (http://www.unitar.org/ny). 
Global and regional strategies
World Health Assembly resolution WHA61.19 (WHO, 2008b).
WHO Regional Office for Europe (2010). 
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WHO Regional Office for the Americas (2011). 
WHO Regional Office for South-East Asia (2010). 
WHO Regional Office for Africa (2012).
WHO Regional Office for the Western Pacific (2012).
Other strategies
Mainstreaming gender in health adaptation to climate change (WHO, 2012a). 
Adaptation measures
WHO (2011a) provides a list of measures and future adaptation needs. 
Menne et al. (2008) give suggestions for strengthening health systems. 
Emergency preparedness 
Information on various aspects of emergency preparedness and response is available on the 
WHO headquarters web site (http://www.who.int/hac/techguidance/preparedness/en/):
• risk management.(WHO, 2011b);
• definitions of natural hazards (WHO, 2011c); 
• hazard-specific:
 ◦ health in hot weather (WHO Regional Office for Europe, 2008); 
 ◦ public health advice for heat (WHO Regional Office for Europe, 2011);
 ◦ water supply and sanitation (WHO Regional Office for Europe,  United Nations Economic 
Commission for Europe, 2011); 
• disaster preparedness in the Americas (http://new.paho.org/disasters/newsletter/index.php).
Infectious diseases
• International Health Regulations (WHO, 2005). 
• Integrated vector management (WHO, 2013). 
• Control of vector-borne disease (WHO Regional Office for the Western Pacific, 2012). 
• Water and health (http://www.who.int/topics/water/en/).
• Food safety (http://www.who.int/foodsafety/en/).
Air pollution
• Air pollution (http://www.who.int/topics/air_pollution/en/).
• Black smoke (WHO Regional Office for Europe, 2012). 
• Indoor environment (National Research Council, 2011). 
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Mental health
• Prevention of suicide (WHO, 2012b). 
• WHO mental health gap action programme (http://www.who.int/mental_health/mhgap/en/).
Migration
• Forced migration (Piguet, 2008). 
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Annex 2. Useful data sources
Mortality and burden of disease
• Mortality statistics, country data and WHO estimates (http://www.who.int/healthinfo/
statistics/mortality/en/index.html and http://www.who.int/gho/countries/en/index.html).
• Over 50 datasets on health priorities, including mortality and burden of disease, the 
Millennium Development Goals, noncommunicable diseases and risk factors, epidemic-
prone diseases, health systems, environmental health, violence and injuries and equity 
(http://apps.who.int/gho/data/view.main).
• Climate change and burden of disease by region (http://apps.who.int/gho/data/node.
main.132?lang=en).
• Detailed mortality database for Europe (International Classification of Diseases, revisions 
9 and 10 and mortality tabulation list of the revision 10) (http://data.euro.who.int/dmdb/.
• European Surveillance System database on infectious diseases (only for experts nominated 
by European Union member states; subsets available for researchers after due process) 
(http://ecdc.europa.eu/en/activities/surveillance/tessy/pages/tessy.aspx).
• World development indicators: economic indicators and country indicators in several fields 
(http://data.worldbank.org/data-catalog/world-development-indicators).
Environment
• European environmental indicators, including several types of health-relevant climatic 
impacts (http://www.eea.europa.eu/data-and-maps).
• United Nations Environment Programme (http://www.unep.org).
Current and past meteorological data
• World climate applications and services programme (http://www.wmo.int/pages/prog/wcp/
wcasp/wcasp_home_en.html).
• Humanitarian early warning service (http://www.hewsweb.org).
• Climate prediction centre (http://www.cpc.ncep.noaa.gov).
• National climate services (http://www.climate.gov).
• International Research Institute for Climate and Society, Earth Institute Lamont-Doherty 
Earth Observatory climate data library (http://iridl.ldeo.columbia.edu/).
• International Research Institute for Climate and Health resource room (http://iridl.ldeo.
columbia.edu/maproom/.Health/).
Climate change scenarios
• Inventory of United Nations climate change learning and training materials (http://www2.
unitar.org/oneun/in ventory/database/inventory_search_rv1.aspx).
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